The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue

By Iscan M.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 1, 2001-11 ,pp. : 47-54

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 31-58

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro

By Jeong Seongwook   Woo Margaret   Flockhart David   Desta Zeruesenay  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 867-875

Springer Publishing Company

Access to resources Recommend Favorite

Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis

By Sergentanis Theodoros  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 459-469

Springer Publishing Company

Access to resources Recommend Favorite

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women

By Singh Virendra   Rastogi Neeraj   Sinha Ashima   Kumar Abhai   Mathur Neeraj   Singh Mahendra  

Breast Cancer Research and Treatment, Vol. 102, Iss. 2, 2007-04 ,pp. : 249-249

Springer Publishing Company

Access to resources Recommend Favorite